Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre

International Journal of Clinical Practice

Volumn 63, Issue 4, 2009, Pages 583-590

  Cubas, E R ^a   Paz Filho, G J ^a   Olandoski, M ^b   Goedert, C A ^c   Woellner, L C ^d   Carvalho, G A ^a   Graf, H ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^c Centro de Tomografia Computadorizada   (Brazil)

^d Centro de Medicina Nuclear   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROPRANOLOL DERIVATIVE; RECOMBINANT HUMAN THYROTROPIN; RECOMBINANT THYROTROPIN; THIAMAZOLE; THYROTROPIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; AGED; ANXIETY; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG UPTAKE; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GOITER; HEADACHE; HEART PALPITATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE URINE LEVEL; LOW DRUG DOSE; MALE; NECK PAIN; NODULAR GOITER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; THYROGLOBULIN BLOOD LEVEL; THYROID VOLUME; THYROID WEIGHT; THYROTROPIN BLOOD LEVEL; URINE LEVEL;

AGED; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; THYROTROPIN; TREATMENT OUTCOME;

EID: 62549140986     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01904.x     Document Type: Article

References (29)

1. Krohn K, Fuhrer D, Bayer Y et al. Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 2005 26 : 504 24.
2. Samuels MH. Editorial: evaluation and treatment of sporadic nontoxic goiter - some answers and more questions. J Clin Endocrinol Metab 2001 86 : 994 7.
3. Bonnema SJ, Bertelsen H, Mortensen J et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 1999 84 : 3636 41.
4. de Klerk JM, van Isselt JW, van Dijk A et al. Iodine-131 therapy in sporadic nontoxic goiter. J Nucl Med 1997 38 : 372 6.
5. Hegedus L, Hansen BM, Knudsen N, Hansen JM. Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. BMJ 1988 297 : 661 2.
6. Huysmans DA, Hermus AR, Corstens FH et al. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994 121 : 757 62.
7. Le Moli R, Wesche MF, Tiel-Van Buul MM, Wiersinga WM. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol (Oxf) 1999 50 : 783 9.
8. Nygaard B, Hegedus L, Gervil M et al. Radioiodine treatment of multinodular non-toxic goitre. BMJ 1993 307 : 828 32.
9. Wesche MF, Tiel VBMM, Lips P et al. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 2001 86 : 998 1005.
10. Wesche MF, Tiel-v-Buul MM, Smits NJ, Wiersinga WM. Reduction in goiter size by 131I therapy in patients with non-toxic multinodular goiter. Eur J Endocrinol 1995 132 : 86 7.
11. Huysmans DA, Buijs WC, van de Ven MT et al. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters. J Nucl Med 1996 37 : 2072 9.
12. Ramirez L, Braverman LE, White B, Emerson CH. Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects. J Clin Endocrinol Metab 1997 82 : 2836 9.
13. Robbins RJ, Voelker E, Wang W et al. Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature. Endocr Pract 2000 6 : 460 4.
14. Ladenson PW, Ewertz ME, Dickey RA. Practical application of recombinant thyrotropin testing in clinical practice. Endocr Pract 2001 7 : 195 201.
15. Huysmans DA, Nieuwlaat WA, Erdtsieck RJ et al. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 2000 85 : 3592 6.
16. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F et al. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab 2001 86 : 5330 6.
17. Silva MNC, Rubio IGS, Romao R et al. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol 2004 60 : 300 8.
18. Torres MST, Ramirez L, Simkin PH et al. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 2001 86 : 1660 4.
19. Albino CC, Mesa CO Jr., Olandoski M et al. Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 2005 90 : 2775 80.
20. Paz-Filho G, Mesa C, Carvalho G et al. Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after two years. Clin Endocrinol (Oxf) 2007 69 : 345 6.
21. Paz-Filho GJ, Mesa-Junior CO, Olandoski M et al. Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone. Braz J Med Biol Res 2007 40 : 1661 70.
22. Nielsen VE, Bonnema SJ, Hegedus L. The effects of recombinant human thyrotropin, in normal subjects and patients with goitre. Clin Endocrinol 2004 61 : 655 63.
23. Bonnema SJ, Nielsen VE, Boel-Jorgensen H et al. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. J Clin Endocrinol Metab 2007 92 : 3424 8.
24. Cohen O, Ilany J, Hoffman C et al. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients. Eur J Endocrinol 2006 154 : 243 52.
25. Nielsen VE, Bonnema SJ, Boel-Jorgensen H et al. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 2006 166 : 1476 82.
26. Nieuwlaat WA, Huysmans DA, van den Bosch HC et al. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 2003 88 : 3121 9.
27. Silva MN, Rubio IG, Romao R et al. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 2004 60 : 300 8.
28. Zelmanovitz FZT, Zelmanovitz W. Radioactive iodine 131 treatment of nontoxic multinodular goiter with ambulatory doses. Endocr J (Japan) 2000 47 (Suppl.) : 144 (Program of the 12th Thyroid Congress, Kyoto, Japan).
29. Pedersen-Bjergaard U, Kirkegaard C. Serum TSH and the response to radioiodine treatment of toxic multinodular goitre. Eur J Endocrinol 1997 137 : 365 9.